# LV20.19 CAR T-Cells in Combination With Pirtobrutinib for Relapsed, Refractory B-cell Malignancies

> clinical trial · VERIFIED · 2026-08-06

Status: RECRUITING · Sponsor: Medical College of Wisconsin · Condition: Non Hodgkin Lymphoma

- Company: Medical College of Wisconsin
- Sector: oncology
- Primary source: https://clinicaltrials.gov/study/NCT05990465

---
Source: MedFuel Intel news monitor. Verification tier: VERIFIED. Informational only, not investment advice. Corrections: media@medfuelinc.com.